
Elegen
Developer of microfluidics technology designed to disrupt synthetic biology. The company leverages technology for the engineering of entire genomes and the rapid development of DNA synthesizers aimed ...
Valuation
$100M
Latest known
Share Price
N/A
Total Raised
$56.6M
Last Round
N/A